Common Shares Outstanding: The number of class A shares currently held by investors.
Tenaya Therapeutics, Inc. (TNYA) had Common Shares Outstanding of 216.76M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-20.18M |
|
-- |
|
-- |
|
$20.77M |
|
$-20.77M |
|
$0.60M |
|
$-20.18M |
|
$-20.18M |
|
$-20.18M |
|
$-20.18M |
|
$-20.18M |
|
$-20.18M |
|
$-20.77M |
|
$-18.95M |
|
152.97M |
|
152.97M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$105.59M |
|
$27.67M |
|
$41.34M |
|
$146.92M |
|
$15.44M |
|
-- |
|
$8.22M |
|
$23.66M |
|
$123.27M |
|
$123.27M |
|
$123.27M |
|
|
Common Shares Outstanding |
216.76M |
| Cash Flow Statement Financials | |
$-68.26M |
|
$56.08M |
|
$108.41M |
|
$4.74M |
|
$100.97M |
|
$96.22M |
|
$13.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.84 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-68.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.37% |
|
-16.37% |
|
-13.73% |
|
-16.37% |
|
$0.57 |
|
$-0.45 |
|
$-0.45 |
|